Skip to content

Just in

4:04 AMIndiana High School Football Scores: The Battle for the Title 4:03 AMJapão 3 x 2 Brasil: Seleção Brasileira derrotada nos acréscimos em Singapura 4:03 AMAvengers: Endgame Encore Breaks Box Office Barriers with New Footage 3:04 AMIntensified Conflict in Donbas: Russia Pushes Further into Eastern Ukraine 3:04 AMStockholm Open Final: Taylor Fritz Faces First-Time Finalist Thiago Agustin Tirante 3:03 AMJapan Outplays Brazil in Thrilling Comeback Victory 3:03 AMSpaceX's Starship Flight 15: A Triumphant Launch Marred by a Catastrophic Booster Explosion 2:06 AMSecretary of Transportation Announces Major Airspace Changes 2:05 AMThe US's Loss of Measles Elimination Status: A Wake-Up Call for Public Health 2:04 AMThe Charlotte Marathon 2026: A Historic Sellout and New Leadership

Topics

Wegovy

Every story about Wegovy, updated as news breaks.

3 stories·Updated Nov 10

What to know

FDA warns of NAION risk with GLP‑1 receptor agonists Nov 10
Over 125 trials show about 6 cases per 100,000 users after one year Nov 10
FDA added new warnings to Ozempic, Zepbound, Wegovy and Mounjaro for NAION risk. Nov 9
Patients should watch for sudden vision loss or blurred vision and report changes immediately. Nov 9
The FDA approved the Wegovy pill, the first GLP‑1 oral medication for obesity. Dec 22

Timeline

Nov 10, 2026

Health
FDA warns GLP‑1 drugs may cause rare vision loss

Nov 10·2 min read
Nov 9, 2026

Health
FDA warns Ozempic and Zepbound may cause rare eye condition

Nov 9·3 min read
Dec 22, 2025

Health
Novo Nordisk’s Wegovy pill approved by FDA

Dec 22·2 min read